Well, good morning and welcome, my health master's family to the worldwide broadcast of the Ted and Austin Brower show, bringing you the latest world news and health research.

I hope you all are having a fantastic day today.

Hope you guys enjoyed yesterday's show.

Myself, Doug, and Ted, we had a great show together,

went into detail on what is going on with these shots,

what is going on with the graphene oxide,

and a whole host of other topics.

So I encourage you,

if you didn't listen to yesterday's show,

be sure to check it out. And I saw an article this morning. And it's almost comical, but it's not comical at all. It just made me chuckle when I saw it because we knew this was going to be the next phase. And it was from the daily mail. And this is the title. I'm just going to read you the title then i'm going to read you

part of the story the title is can long covid be cured by a monthly dose of the vaccine a major

british trial is about to find out in a world first british scientists are setting to explore giving COVID patients monthly doses

of the COVID vaccine. Funding, of course, is being offered by several of the major vaccine

manufacturers. And if the pilot is successful, the scientists involved have been told they can recruit

thousands of more patients

for a more in-depth study. The manufacturers are funding the study, and they said they saw a

dramatic improvement within days of people getting the jab. Of course, of course they said that.

They said, but it only lasted for about a month after the first dose. And then symptoms of COVID seem to appear again.

So the scientists believe roughly 1 in 10 people catch COVID suffer prolonged symptoms,

including shortness of breath, muscle aches, and problems with thinking and concentration.

They said the jab cost only about 15 pounds.

And the trial will be the first time in the world a vaccine, they call it a vaccine. It's not vaccine. It's gene therapy. A vaccine will be used for any purpose other than protecting people against the virus itself. They said at a time when vaccines are in short supplies, expected to raise ethical questions.

...